ArticleLife (Basel, Switzerland)2022

Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project.

Enrico Bernardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.